Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

14-11-2018 | Original Paper

Prevalence and Predictors of Anxiety Disorders in Adolescent and Adult Males with Autism Spectrum Disorder and Fragile X Syndrome

Auteurs: Jordan Ezell, Abigail Hogan, Amanda Fairchild, Kimberly Hills, Jessica Klusek, Leonard Abbeduto, Jane Roberts

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 3/2019

Abstract

Anxiety disorders affect ~ 15–20% of youths without neurodevelopmental disorders, with persons having autism spectrum disorder (ASD) and fragile X syndrome (FXS) at elevated risk for anxiety disorders. Few studies have compared rates and predictors of anxiety disorders in adolescents with FXS or ASD. This study directly compares rates, predictors, and medication of anxiety disorders between age-matched, male adolescents with FXS (n = 31) or ASD (n = 20). Results indicate that 51.6% of FXS and 50.0% of ASD adolescents met criteria for an anxiety disorder. Cognitive scores and ASD severity did not predict anxiety. Of those with anxiety, ~ 40% of the FXS and 20% of the ASD participants were prescribed medications for anxiety.

vorige artikel Effects of Delay, Question Type, and Socioemotional Support on Episodic Memory Retrieval by Children with Autism Spectrum Disorder

volgende artikel Supporting Parents of a Child with Autism Spectrum Disorder: The French Awakening

American Psychiatric Association. (2013). DSM-V. American Journal of Psychiatry. https://doi.org/10.1176/appi.books.9780890425596.744053.CrossRef

Bailey, D. B., Hatton, D. D., Mesibov, G., Ament, N., & Skinner, M. (2000). Early development, temperament, and functional impairment in autism and fragile X syndrome. Journal of Autism and Developmental Disorders, 30(1), 49–59. https://doi.org/10.1023/A:1005412111706.PubMedCrossRef

Bailey, D. B., Raspa, M., Bishop, E., Olmsted, M., Mallya, U. G., & Berry-kravis, E. (2012). Medication utilization for targeted symptoms in children and adults with fragile X syndrome: US survey. Journal of Developmental and Behavioral Pediatrics, 33(1), 62–69.PubMedCrossRef

Bailey, D. B., Raspa, M., Olmsted, M., & Holiday, D. B. (2008). Co-occurring conditions associated with FMR1 gene variations: Findings from a national parent survey. American Journal of Medical Genetics, Part A, 146(16), 2060–2069. https://doi.org/10.1002/ajmg.a.32439.CrossRef

Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., et al. (2018). Prevalence of autism spectrum disorder among children aged 8 years—Autism and developmental disabilities monitoring network, 11 sites, United States, 2014. MMWR Surveill Summ, 67(6), 1–23.PubMedPubMedCentralCrossRef

Bakken, T. L., Helverschou, S. B., Eilertsen, D. E., Heggelund, T., Myrbakk, E., & Martinsen, H. (2010). Psychiatric disorders in adolescents and adults with autism and intellectual disability: A representative study in one county in Norway. Research in Developmental Disabilities, 31(6), 1669–1677. https://doi.org/10.1016/j.ridd.2010.04.009.PubMedCrossRef

Beesdo, K., Knappe, S., & Pine, D. S. (2011). Anxiety and anxiety disorders in children and adolescents: Developmental issues and implications for DSM-V. Psychiatric Clinics of North America, 32(3), 483–524. https://doi.org/10.1016/j.psc.2009.06.002.Anxiety.CrossRef

Bellini, S. (2006). The development of social anxiety in adolescents with autism spectrum disorders. Focus on Autism and Other Developmental Disabilities, 21(3), 138–145. https://doi.org/10.1177/10883576060210030201.CrossRef

Berry-Kravis, E., Knox, A., & Hervey, C. (2011). Targeted treatments for fragile X syndrome. Journal of Neurodevelopmental Disorders, 3(3), 193–210. https://doi.org/10.1007/s11689-011-9074-7.PubMedPubMedCentralCrossRef

Berry-Kravis, E., & Potanos, K. (2004). Psychopharmacology in fragile X syndrome? Present and future. Mental Retardation and Developmental Disabilities Research Reviews. https://doi.org/10.1002/mrdd.20007.PubMedCrossRef

Buck, T. R., Viskochil, J., Farley, M., Coon, H., Mcmahon, W. M., Morgan, J., & Bilder, D. A. (2014). Psychiatric comorbidity and medication use in adults with autism spectrum disorder. JADD, 44, 3063–3071. https://doi.org/10.1007/s10803-014-2170-2.CrossRef

Cohen, I. L. (1995). A theoretical analysis of the role of hyperarousal in the learning and behavior of fragile X males. Mental Retardation and Developmental Disabiliites Research Reviews, 1, 286–291.CrossRef

Cohen, I. L., Fisch, G. S., Sudhalter, V., Wolf-Schein, E. G., Hanson, D., Hagerman, R., … Brown, W. T. (1988). Social gaze, social avoidance, and repetitive behavior in fragile X males: A controlled study. American Journal of Mental Retardation: AJMR, 92(5), 436–446.PubMed

Cordeiro, L., Ballinger, E., Hagerman, R., & Hessl, D. (2011). Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: Prevalence and characterization. Journal of Neurodevelopmental Disorders, 3(1), 57–67. https://doi.org/10.1007/s11689-010-9067-y.PubMedCrossRef

Coury, D. L., Anagnostou, E., Manning-Courtney, P., Reynolds, A., Cole, L., McCoy, R., … Perrin, J. M. (2012). Use of psychotropic medication in children and adolescents with autism spectrum disorders. Pediatrics, 130(Supplement 2), S69–S76. https://doi.org/10.1542/peds.2012-0900D.PubMedCrossRef

de Bruin, E. I., Ferdinand, R. F., Meester, S., de Nijs, P. F. A., & Verheij, F. (2007). High rates of psychiatric co-morbidity in PDD-NOS. Journal of Autism & Developmental Disorders, 37(5), 877–886.CrossRef

Erickson, C. A., Davenport, M. H., Schaefer, T. L., Wink, L. K., Pedapati, E. V., Sweeney, J. A., et al. (2017). Fragile X targeted pharmacotherapy: Lessons learned and future directions. Journal of Neurodevelopmental Disorders, 7, 1–14. https://doi.org/10.1186/s11689-017-9186-9.CrossRef

Gadow, K. D., Sprafkin, J., & Nolan, E. E. (2001). DSM-IV symptoms in community and clinic preschool children. Journal of the American Academy of Child & Adolescent Psychiatry, 40(12), 1383–1392. https://doi.org/10.1097/00004583-200112000-00008.CrossRef

Garber, K. B., Visootsak, J., & Warren, S. T. (2008). Fragile X syndrome. European Journal of Human Genetics, 16(6), 666–672. https://doi.org/10.1038/ejhg.2008.61.PubMedCrossRef

Gotham, K., Pickles, A., & Lord, C. (2012). Trajectories of autism severity in children using standardized ADOS scores. Pediatrics, 130(5), e1278–e1284. https://doi.org/10.1542/peds.2011-3668.PubMedPubMedCentralCrossRef

Green, J., Gilchrist, A., Burton, D., & Cox, A. (2000). Social and psychiatric functioning in adolescents with Asperger syndrome compared with conduct disorder. Journal of Autism and Developmental Disorders, 30(4), 279–293. https://doi.org/10.1023/A:1005523232106.PubMedCrossRef

Grisham, J. R., Brown, T. A., & Campbell, L. A. (2004). The anxiety disorders interview schedule for DSM-IV (ADIS-IV). In Comprehensive handbook of psychological assessment, Vol. 2: personality assessment (pp. 163–177). http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=N&PAGE=fulltext&AN=2004-12821-014&D=psyc4.

Hagerman, R., Lauterborn, J., Au, J., & Berry-Kravis, E. (2012). Fragile X syndrome and targeted treatment trials. Results and Problems in Cell Differentiation, 54, 297–335. https://doi.org/10.1007/978-3-642-21649-7_17.PubMedPubMedCentralCrossRef

Hall, S. S., Lightbody, A. A., & Reiss, A. L. (2008). Compulsive, self-injurious, and autistic behavior in children and adolescents with fragile X syndrome. American Journal of Mental Retardation. https://doi.org/10.1352/0895-8017(2008)113[44:CSAABI]2.0.CO;2.PubMedCrossRef

Hall, S. S., & Venema, K. M. (2017). A screening tool to measure eye contact avoidance in boys with fragile X syndrome. Journal of Autism and Developmental Disorders, 47(7), 2254–2264. https://doi.org/10.1007/s10803-017-3139-8.PubMedPubMedCentralCrossRef

Helverschou, S. B., & Martinsen, H. (2011). Anxiety in people diagnosed with autism and intellectual disability: Recognition and phenomenology. Research in Autism Spectrum Disorders, 5(1), 377–387. https://doi.org/10.1016/J.RASD.2010.05.003.CrossRef

Hessl, D., Dyer-Friedman, J., Glaser, B., Wisbeck, J., Barajas, R. G., Taylor, A., & Reiss, A. L. (2001). The influence of environmental and genetic factors on behavior problems and autistic symptoms in boys and girls with fragile X syndrome. Pediatrics, 108(5), e88–e88. https://doi.org/10.1542/peds.108.5.e88.PubMedCrossRef

Hessl, D., Glaser, B., Dyer-Friedman, J., & Reiss, A. L. (2006). Social behavior and cortisol reactivity in children with fragile X syndrome. Journal of Child Psychology and Psychiatry and Allied Disciplines, 47(6), 602–610. https://doi.org/10.1111/j.1469-7610.2005.01556.x.CrossRef

Hooper, S. R., Hatton, D. D., Baranek, G. T., Roberts, J. P., & Bailey, D. B. (2000). Nonverbal assessment of IQ, attention, and memory abilities in children with fragile-X syndrome using the Leiter-R. Journal of Psychoeducational Assessment, 18(3), 255–267. https://doi.org/10.1177/073428290001800305.CrossRef

Kaufmann, W. E., Cortell, R., Kau, A. S. M., Bukelis, I., Tierney, E., Gray, R. M., … Stanard, P. (2004). Autism spectrum disorder in fragile X syndrome: Communication, social interaction, and specific behaviors. American Journal of Medical Genetics. https://doi.org/10.1002/ajmg.a.30229.CrossRefPubMed

Kerns, C. M., Kendall, P. C., Berry, L., Souders, M. C., Franklin, M. E., Schultz, R. T., et al. (2014). Traditional and atypical presentations of anxiety in youth with autism spectrum disorder. Journal of Autism and Developmental Disorders, 44(11), 2851–2861. https://doi.org/10.1007/s10803-014-2141-7.PubMedPubMedCentralCrossRef

Kerns, C. M., Kendall, P. C., Wood, J. J., & Storch, E. a. (2017). Anxiety disorders interview schedule–autism addendum: Reliability and validity in children with autism spectrum disorder. Journal of Clinical Child & Adolescent Psychology, 46(1), 88–100. https://doi.org/10.1080/15374416.2016.1233501.CrossRef

Kerns, C. M., Kendall, P. C., Zickgraf, H., Franklin, M. E., Miller, J., & Herrington, J. (2015). Not to be overshadowed or overlooked: Functional impairments associated with comorbid anxiety disorders in youth with ASD. Behavior Therapy, 46(1), 29–39. https://doi.org/10.1016/j.beth.2014.03.005.PubMedCrossRef

Kim, J. A., Szatmari, P., Bryson, S. E., Streiner, D. L., & Wilson, F. J. (2000). The prevalence of anxiety and mood problems among children with autism and asperger syndrome. Autism, 4(2), 117–132. https://doi.org/10.1177/1362361300004002002.CrossRef

Klusek, J., Martin, G. E., & Losh, M. (2014). Consistency between research and clinical diagnoses of autism among boys and girls with fragile X syndrome. Journal of Intellectual Disability Research. https://doi.org/10.1111/jir.12121.PubMedCrossRef

Klusek, J., Roberts, J. E., & Losh, M. (2015). Cardiac autonomic regulation in autism and fragile X syndrome: A review. Psychological Bulletin, 141(1), 141–175. https://doi.org/10.1037/a0038237.PubMedCrossRef

Kuusikko, S., Pollock-Wurman, R., Jussila, K., Carter, A. S., Mattila, M. L., Ebeling, H., … Moilanen, I. (2008). Social anxiety in high-functioning children and adolescents with autism and Asperger syndrome. Journal of Autism and Developmental Disorders, 38(9), 1697–1709. https://doi.org/10.1007/s10803-008-0555-9.PubMedCrossRef

Lachiewicz, A. M., & Dawson, D. V. (1994). Behavior problems of young girls with fragile X syndrome: Factor scores on the Conners’ Parent’s Questionnaire. American Journal of Medical Genetics, 51(4), 364–369. https://doi.org/10.1002/ajmg.1320510413.PubMedCrossRef

Laxman, D. J., Greenberg, J. S., DaWalt, L. S., Hong, J., Aman, M. G., & Mailick, M. (2017). Medication use by adolescents and adults with fragile X syndrome. Journal of Intellectual Disability Research, 1400, 1–12. https://doi.org/10.1111/jir.12433.CrossRef

Lee, M., Martin, G. E., Berry-Kravis, E., & Losh, M. (2016). A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndrome. Journal of Neurodevelopmental Disorders. https://doi.org/10.1186/s11689-016-9179-0.PubMedPubMedCentralCrossRef

Leyfer, O. T., Folstein, S. E., Bacalman, S., Davis, N. O., Dinh, E., Morgan, J., et al. (2006). Comorbid psychiatric disorders in children with autism: Interview development and rates of disorders. Journal of Autism and Developmental Disorders, 36(7), 849–861. https://doi.org/10.1007/s10803-006-0123-0.PubMedCrossRef

Lord, C., Rutter, M., DiLavore, P., Risi, S., & Gotham, K. (2012). Autism diagnostic observation schedule, (ADOS-2). Modules 1–4. Los Angeles, CA: Western Psychological Services.

Matherly, S. M., Klusek, J., Thurman, A. J., McDuffie, A., Abbeduto, L., & Roberts, J. E. (2018). Cortisol profiles differentiated in adolescents and young adult males with fragile X syndrome versus autism spectrum disorder. Developmental Psychobiology, 60(1), 78–89. https://doi.org/10.1002/dev.21578.PubMedCrossRef

Matson, J. L., Smiroldo, B. B., Hamilton, M., & Baglio, C. S. (1997). Do anxiety disorders exist in persons with severe and profound mental retardation? Research in Developmental Disabilities. https://doi.org/10.1016/S0891-4222(96)00036-4.CrossRefPubMed

Muris, P., Steerneman, P., Merckelbach, H., Holdrinet, I., & Meesters, C. (1998). Comorbid anxiety symptoms in children with pervasive developmental disorders. Journal of Anxiety Disorders, 12(4), 387–393. https://doi.org/10.1016/s0887-6185(98)00022-x.PubMedCrossRef

R Core Team. (2013). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org/.

Renno, P., & Wood, J. J. (2013). Discriminant and convergent validity of the anxiety construct in children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 43(9), 2135–2146. https://doi.org/10.1007/s10803-013-1767-1.PubMedPubMedCentralCrossRef

Rinehart, N. J., Cornish, K. M., & Tonge, B. J. (2011). Gender differences in neurodevelopmental disorders: Autism and fragile X syndrome. Current Topics in Behavioral Neurosciences. https://doi.org/10.1007/7854_2010_96.PubMedCrossRef

Roberts, J. E., Clarke, M. A., Alcorn, K., Carter, J. C., Long, A. C. J., & Kaufmann, W. E. (2009). Autistic behavior in boys with fragile X syndrome: Social approach and HPA-axis dysfunction. Journal of Neurodevelopmental Disorders, 1(4), 283–291. https://doi.org/10.1007/s11689-009-9028-5.PubMedPubMedCentralCrossRef

Roberts, J. E., Ezell, J. E., Fairchild, A. J., Klusek, J., Thurman, A. J., McDuffie, A., & Abbeduto, L. (2018). Biobehavioral composite of social aspects of anxiety in young adults with fragile X syndrome contrasted to autism spectrum disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. https://doi.org/10.1002/ajmg.b.32674.CrossRef

Rodgers, J., & Ofield, A. (2018). Understanding, recognising and treating co-occurring anxiety in autism. Current Developmental Disorders Reports, 5(1), 58–64. https://doi.org/10.1007/s40474-018-0132-7.PubMedPubMedCentralCrossRef

Rogers, S. J., Wehner, E. A., & Hagerman, R. (2001). The behavioral phenotype in fragile X: Symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders. Journal of Developmental and Behavioral Pediatrics, 22(6), 409–417. https://doi.org/10.1097/00004703-200112000-00008.PubMedCrossRef

Roid, G. H., & Miller, L. J. (1997). Leiter international performance scale-revised. Wood Dale, IL: Stoelting.

Rosenberg, R. E., Mandell, D. S., Farmer, J. E., Law, J. K., Marvin, A. R., & Law, P. A. (2010). Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007–2008. J Autism Dev Disord, 40(3), 342–351. https://doi.org/10.1007/s10803-009-0878-1.PubMedCrossRef

Salum, G. A., De Sousa, D. A., do Rosário, M. C., Pine, D. S., & Manfro, G. G. (2013). Pediatric anxiety disorders: From neuroscience to evidence-based clinical practice. Revista Brasileira de Psiquiatria, 35(SUPPL. 1), 3–21. https://doi.org/10.1590/1516-4446-2013-S108.CrossRef

Schwarte, A. R. (2008). Fragile X syndrome. School Psychology Quarterly, 23, 290–300. https://doi.org/10.1038/ejhg.2008.61.CrossRef

Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008). Psychiatric disorders in children with autism spectrum disorders: Prevalence, comorbidity, and associated factors in a population-derived sample. Journal of the American Academy of Child and Adolescent Psychiatry, 47(8), 921–929. https://doi.org/10.1097/CHI.0b013e318179964f.PubMedCrossRef

Sukhodolsky, D. G., Bloch, M. H., Panza, K. E., Reichow, B., Kanner, L., de Bruin, E., et al. (2013). Cognitive-behavioral therapy for anxiety in children with high-functioning autism: A meta-analysis. Pediatrics, 132(5), e1341–e1350. https://doi.org/10.1542/peds.2013-1193.PubMedPubMedCentralCrossRef

Sukhodolsky, D. G., Scahill, L., Gadow, K. D., Arnold, L. E., Aman, M. G., McDougle, C. J., et al. (2008). Parent-rated anxiety symptoms in children with pervasive developmental disorders: Frequency and association with core autism symptoms and cognitive functioning. Journal of Abnormal Child Psychology, 36(1), 117–128. https://doi.org/10.1007/s10802-007-9165-9.PubMedCrossRef

Talisa, V. B., Boyle, L., Crafa, D., & Kaufmann, W. E. (2014). Autism and anxiety in males with fragile X syndrome: An exploratory analysis of neurobehavioral profiles from a parent survey. American Journal of Medical Genetics, Part A, 164(5), 1198–1203. https://doi.org/10.1002/ajmg.a.36468.CrossRef

Thurman, A. J., McDuffie, A., Hagerman, R., & Abbeduto, L. (2014). Psychiatric symptoms in boys with fragile X syndrome: A comparison with nonsyndromic autism spectrum disorder. Research in Developmental Disabilities, 35(5), 1072–1086. https://doi.org/10.1016/j.ridd.2014.01.032.PubMedPubMedCentralCrossRef

van Steensel, F. J. A., Bögels, S. M., & Perrin, S. (2011). Anxiety disorders in children and adolescents with autistic spectrum disorders: A meta-analysis. Clinical Child and Family Psychology Review, 14(3), 302–317. https://doi.org/10.1007/s10567-011-0097-0.PubMedPubMedCentralCrossRef

Van Steensel, F. J. A., Bögels, S. M., & Wood, J. J. (2013). Autism spectrum traits in children with anxiety disorders. Journal of Autism and Developmental Disorders, 43(2), 361–370. https://doi.org/10.1007/s10803-012-1575-z.PubMedCrossRef

Vasa, R. A., Mazurek, M. O., Mahajan, R., Bennett, A. E., Bernal, M. P., Nozzolillo, A. A., et al., (2017). Assessment and treatment of anxiety in youth with autism spectrum disorders. Pediatrics, 137(Suppl 2), S115–S123. https://doi.org/10.1542/peds.2015-2851J.CrossRef

Venker, C. E., Ray-Subramanian, C. E., Bolt, D. M., & Weismer, S. E. (2014). Trajectories of autism severity in early childhood. Journal of Autism and Developmental Disorders, 44(3), 546–563. https://doi.org/10.1007/s10803-013-1903-y.PubMedPubMedCentralCrossRef

Wehry, A. M., Beesdo-baum, K., Hennelly, M. M., Connolly, S. D., & Strawn, J. R. (2015). Assessment and treatment of anxiety disorders in children and adolescents. Current Psychiatry Reports, 17(7), 1–19. https://doi.org/10.1007/s11920-015-0591-z.Assessment.CrossRef

Weller, E. B., Weller, R., Fristad, M.A., Rooney, M. T., & Schecter, J. (2000). Children’s interview for psychiatric syndromes (ChIPS). Journal of the American Academy of Child and Adolescent Psychiatry, 39(1), 76–84. https://doi.org/10.1097/00004583-200001000-00019.PubMedCrossRef

White, S. W., Mazefsky, C. A., Dichter, G. S., Chiu, P. H., Richey, J. A., & Ollendick, T. (2014). Social-cognitive, physiological, and neural mechanisms underlying emotion regulation impairments: Understanding anxiety in autism spectrum disorder. International Journal of Developmental Neuroscience, 39(540), 22–36.PubMedPubMedCentralCrossRef

White, S. W., Oswald, D., Ollendick, T., & Scahill, L. (2009). Anxiety in children and adolescents with autism spectrum disorders. Clinical Psychology Review, 29(3), 216–229. https://doi.org/10.1016/j.cpr.2009.01.003.PubMedPubMedCentralCrossRef

Witwer, A. N., & Lecavalier, L. (2010). Validity of comorbid psychiatric disorders in youngsters with autism spectrum disorders. Journal of Developmental and Physical Disabilities, 22(4), 367–380. https://doi.org/10.1007/s10882-010-9194-0.CrossRef

Witwer, A. N., Lecavalier, L., & Norris, M. (2012). Reliability and validity of the children’s interview for psychiatric syndromes-parent version in autism spectrum disorders. Journal of Autism and Developmental Disorders, 42(9), 1949–1958. https://doi.org/10.1007/s10803-012-1442-y.PubMedCrossRef

Wood, J. J., & Gadow, K. D. (2010). Exploring the nature and function of anxiety in youth with autism spectrum disorders. Clinical Psychology: Science and Practice, 17(4), 281–292. https://doi.org/10.1111/j.1468-2850.2010.01220.x.CrossRef

Titel: Prevalence and Predictors of Anxiety Disorders in Adolescent and Adult Males with Autism Spectrum Disorder and Fragile X Syndrome
Auteurs: Jordan Ezell
Abigail Hogan
Amanda Fairchild
Kimberly Hills
Jessica Klusek
Leonard Abbeduto
Jane Roberts
Publicatiedatum: 14-11-2018
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 3/2019
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-018-3804-6

Andere artikelen Uitgave 3/2019

The Role of Child Problem Behaviors in Autism Spectrum Symptoms and Parenting Stress: A Primary School-Based Study

Original Paper

Development and Validation of the Camouflaging Autistic Traits Questionnaire (CAT-Q)

Open Access
Original Paper

Life Satisfaction in Adolescents with Autism Spectrum Disorder

Original Paper

Outpatient Psychotherapy for Adults with High-Functioning Autism Spectrum Condition: Utilization, Treatment Satisfaction, and Preferred Modifications

Original Paper

Extending the Parent-Delivered Early Start Denver Model to Young Children with Fragile X Syndrome

Original Paper

Diagnosing Autism Spectrum Disorder in Children with Low Mental Age

Original Paper